At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
Tamoxifendrug
Likely dose
Tamoxifen 5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Low-Dose Tamoxifen to Reduce High Background Parenchymal Uptake on Molecular Breast Imaging
In Brief
A clinical study evaluating Tamoxifen for High Background Uptake on MBI. Completed, enrolled 22 participants across 1 site.
Detailed Summary
The study will examine whether changes in background parenchymal uptake (BPU) on molecular breast imaging (MBI) can be induced by short-term use of low-dose tamoxifen. Women who have previously had high BPU on MBI will be recruited. Participants will take low-dose tamoxifen for a 30-day period, with post-tamoxifen MBI in order to investigate the impact of tamoxifen on BPU.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHigh Background Uptake on MBI
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 2016
Enrollment StartMar 2017
Primary CompletionFeb 2018
Study CompletionNov 2018
TodayJul 2026
First PostedDec 1, 2016
Enrollment StartMar 1, 2017
Primary CompletionFeb 25, 2018
Study CompletionNov 1, 2018
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 9.6 years ago
Interventions
Tamoxifendrug
5 mg or 10 mg tamoxifen per day for 30 days.